CVX vs DHR: Which Is the Better Buy?
Side-by-side comparison of Chevron Corporation and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-24.
Chevron Corporation · Energy
$205.52
+35.9% upside to fair value
Med Conviction
Grade B
High Quality
VS
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
CVX has more upside to fair value
(+35.9%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CVX |
DHR |
| Current Price |
$205.52 |
$221.12 |
| Fair Value Estimate |
$279.29 |
$286.52 |
| Upside to Fair Value |
+35.9%
|
+29.6%
|
| Market Cap |
$409.3B |
$155.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
7.8x
|
24.8x
|
| Price / Sales |
2.0x
|
6.2x
|
| Price / FCF |
15.0x
|
28.5x
|
| Revenue Growth YoY |
+51.4%
|
+5.5%
|
| Gross Margin |
31.0%
|
58.5%
|
| Operating Margin |
15.8%
|
20.4%
|
| Return on Equity |
11.0%
|
7.7%
|
| Dividend Yield |
3.43% |
0.65% |
| FCF Yield |
6.67%
|
3.51%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Chevron is a global integrated oil and gas major organized into Upstream and Downstream segments, spanning crude oil and natural gas exploration, LNG processing and transport, refining, petrochemicals, and lubricants, with 43,039 full-time employees and a market capitalization of $409.31 billion at a current price of $205.52. The business quality is high: it generates $13.71 of free cash flow per…
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Accumulation Zones
| Metric |
CVX |
DHR |
| Zone Low |
$209.47 |
$214.89 |
| Zone High |
$237.40 |
$243.54 |
| In Buy Zone? |
Yes
|
Yes
|